Crow's Feet Lines

15 registered clinical trials studyying Crow's Feet Lines — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Real-World Study on Effect of Hirudoid on Ecchymosis After Treatment of Crow's Feet With Botulinum Toxin Typ NCT07388927	DKSH Management (Thailand) Limited	Phase 4
Not Yet Recruiting	A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement NCT06402058	Samyang Biopharmaceuticals Corporation	N/A
Completed	To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for NCT06376838	DEXLEVO	N/A
Unknown	A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Mo NCT04081402	Huons Co., Ltd.	Phase 3
Completed	Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's F NCT03408236	Hugel	Phase 3
Completed	MEDITOXIN® in Treatment of Crow's Feet Line NCT03317574	Medy-Tox	Phase 3
Unknown	Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension NCT03184363	Daewoong Pharmaceutical Co. LTD.	Phase 3
Completed	Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in K NCT02248844	Allergan	—
Completed	BOTOX® in the Treatment of Crow's Feet Lines in China NCT02195687	Allergan	Phase 3
Completed	Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY NCT02176356	Allergan	Phase 4
Completed	BOTOX® in the Treatment of Upper Facial Lines in Japan NCT01797094	Allergan	Phase 3
Completed	BOTOX® in the Treatment of Crow's Feet Lines in Japan NCT01797081	Allergan	Phase 3
Completed	Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines NCT01224015	Allergan	Phase 3
Completed	Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines NCT01189747	Allergan	Phase 3
Completed	Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines NCT01189760	Allergan	Phase 3